Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Est. Listeners
Insufficient chart data. Estimates will improve as the show charts.
- Per-Episode Audience
Est. listeners per new episode within ~30 days
N/A🎙 ~2x weekly·295 episodes·Last published 3d ago - Monthly Reach
Unique listeners across all episodes (30 days)
N/A - Active Followers
Loyal subscribers who consistently listen
N/A
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
Germany Is the Engine: What BAT Knows That Cannabis Doesn't ft. James Yamanaka
Jun 22, 2026
Unknown duration
Why Ohio Cannabis Is Built Different: Inside the Regulator-Operator Alignment That's Actually Working ft. Caroline Henry
Jun 11, 2026
Unknown duration
Cannabis Was Medicine. Now the Proof Is Catching Up, ft. Joel Stanley and Dr. Marcel Bonn-Miller
May 21, 2026
Unknown duration
Joe Lustberg: What Cannabis Lenders See That Operators Miss
May 15, 2026
Unknown duration
The Hidden Margin Killer for MSOS ft. Braunz Muller
May 8, 2026
Unknown duration
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 6/22/26 | Germany Is the Engine: What BAT Knows That Cannabis Doesn't ft. James Yamanaka | Predictable cash flow is the whole game. In cannabis, predictable is the one thing almost nobody has. Organigram CEO James Yamanaka came up over 20 years at British American Tobacco, where that discipline is the entire model. He thinks the opportunity starts there: trim the portfolio, stop chasing every trend, tighten the supply chain, lean on the science, and align operations. Germany's market could nearly double in the next two years, but capturing it will take more than expansion. This week we sit down with James Yamanaka, CEO of Organigram: A BAT perspective on cannabis Why chasing every trend loses money How the Sanity deal unlocks Germany | — | ||||||
| 6/11/26 | Why Ohio Cannabis Is Built Different: Inside the Regulator-Operator Alignment That's Actually Working ft. Caroline Henry | When a regulator asks what the downside is of adding one more testing requirement, what is the downside? Just a little more safe. Just in case. Especially when adding one more item to an already exhaustive testing panel. That logic is how licensed cannabis markets end up buried under compliance layers copied from other states, calibrated to someone else's problems. It is also exactly how two adjacent markets with nearly identical consumer bases, Ohio and Michigan, ended up with completely different market structures. What they do not share is regulatory philosophy. When one state watches another add a rule and asks itself whether it should do the same, the answer it lands on shapes the entire cost structure of every licensed operator inside its borders. Ohio learned to ask the follow-up question. Most states never do. Ohio closed the intoxicating hemp loophole on March 20th, ahead of the federal government, and those shops are starting to close. The next unlock may already be here: THC beverages reaching the customers who will never walk into a dispensary, sold at the restaurant down the street. This week we sit down with Caroline Henry, VP of Government and Regulatory Affairs at Buckeye Relief. The regulator FOMO problem Ohio vs. Michigan: two markets, one lesson THC beverages as the dispensary gateway | — | ||||||
| 5/21/26 | Cannabis Was Medicine. Now the Proof Is Catching Up, ft. Joel Stanley and Dr. Marcel Bonn-Miller | The cannabis industry convinced the world it had a medicine before the science caught up. Now the science is here, and almost no one is paying attention. CBD is not a panacea. When Charlotte's Web opened hearts and minds, the messaging of what it could do ran years ahead of what the data could actually support. That gap created a backlash the legitimate medical thesis didn't deserve. What's left on the other side of the green rush is a near-complete forgetting of the reason this industry started in the first place. The medicine. Now the infrastructure to prove it is finally in place. Standardized genetics. Reproducible extraction. Full compound characterization. An FDA botanical drug pathway that has existed since 2016 that most investors have never heard of. Organic medicine versus synthetic single-molecule will be a real choice at the pharmacy counter sooner than most people expect. The foundational work is already here. This week we sit down with Joel Stanley and Dr. Marcel Bonn-Miller: Botanical drugs vs. supplements 6,000 compounds, one drug Novel compounds nobody has named yet | — | ||||||
| 5/15/26 | Joe Lustberg: What Cannabis Lenders See That Operators Miss | The cash amount in your head and the cash you actually need are not the same number. That gap is where most cannabis businesses break. Joe Lustberg has financed operators across the country for years and watched that gap swallow businesses that looked fine on paper. He has also spent over two years paying rent on a Hamptons dispensary he cannot open because a municipality tried to rezone his property out from under him. The person telling you to build in 1.5X as your burn capital cushion has been living inside exactly the scenario he warns everyone about. When the lender financing your industry has lived the same nightmare, the advice changes. This week we sit down with Joe Lustberg, to discuss the following NY Regulatory Battlefield 280E Gone: What Changes Lending Specifics | — | ||||||
| 5/8/26 | The Hidden Margin Killer for MSOS ft. Braunz Muller | Cannabis operators aren't short on data. They're drowning in it. The real problem is what happens when that data gets handed to the wrong person, read at the wrong time, or used to justify the wrong decision. Overproduction cycles, steep discounting, margin pressure building back into manufacturing: most of that traces back to data being used reactively instead of as a decision guidance tool. Layer on the reality of multi-state operations where every market runs a different system, tracks different items, and reports differently. Making sense of what the numbers are actually saying across that footprint isn't just a technology problem. It's an interpretation problem with real financial consequences. Think of it like a compass that's slightly off calibrated. Over a short distance, no one notices. Across 15 facilities and hundreds of SKUs, you end up miles from where you intended. This week we sit down with Braunz Muller, to discuss the following Margins in Cannabis Supply Chains Hydrocarbon SOP Secrets THC Efficiency as the Real KPI | — | ||||||
| 4/24/26 | Ed Rosenthal and Greg Baughman: You're Still Growing Cannabis Wrong | A customer walks into the dispensary and asks the budtender for a flower recommendation. They end up with a degraded version of the once high-end flower that graced your cultivation floor. They do not know it. Your brand took the blame. Ed Rosenthal, the most referenced name in cannabis cultivation history, says the cannabis supply chain has a freshness problem that starts in the dry room and compounds at every handoff. The smell of your drying room that everyone loves walking into? Those are your terpenes leaving the building. This week we sit down with Ed Rosenthal and Greg Baughman to discuss: How Canada already solved thisWhy most are still cultivating wrongFreeze drying vs. traditional drying Chapters 00:00 The Freshness Debate: Cannabis vs. Produce 03:01 Consumer Awareness and Dispensary Practices 05:55 Post-Harvest Processing: Ensuring Quality and Consistency 08:59 Innovations in Freeze-Drying Cannabis 11:48 The Science Behind Freeze-Drying: A Deeper Dive 14:52 Testing and Refining the Freeze-Drying Process 17:54 The Future of Cannabis Processing: Quality and Efficiency 28:28 Post-Harvest Efficiency and Cost Reduction 30:26 Cultivation Methods and Labor Costs 35:09 Crisis Management and Industry Change 39:22 Market Maturity and Operational Efficiencies 43:00 Future of Cannabis Cultivation 47:04 Innovations in Drying and Curing Processes 52:46 Consumer Perception and Quality Assurance | — | ||||||
| 4/6/26 | The Legal Market Was Never Built for Payments, Why Cannabis Still Breaks the Rules ft. Aubrey Amatelli | The largest payment processor in the world handles cannabis in Canada. In the U.S., they will not touch it. That’s the gap. Aubrey Amatelli left JP Morgan believing that if you followed the rules, aligned with card brand requirements, and structured things correctly, you could build a compliant, stable payment product. Then came Mastercard shutdowns, a failed tech partner that cost six figures, and a stretch where 5,000 dispensaries lost payment access in a matter of weeks. What came out of that was a different approach to building in cannabis. Redundancy is not a feature. It is the product. This week we sit down with Aubrey Amatelli to discuss the following:• JP Morgan to cannabis payments• A failed partner and six figures lost• Why moving from cash to card changes ticket size | — | ||||||
| 3/27/26 | Gretchen Gailey: Cannabis Industry Has No Idea How DC Works, Why Rescheduling Is Delayed | Politics is a dirty business. Sometimes being feared is the influence you need because access is not the problem. Politicians say "we'll take care of this." Gretchen Gailey has a different approach: stab them in the back, push them down the stairs, and take credit for the fall. It's time to put fear behind cannabis. She spent 20 years on Capitol Hill. She's watched cannabis show up once a year for fly-ins, throw money at the wrong politicians, and wonder why nothing changes. This episode breaks down why incrementalism is the only path, why banking matters more than you think, and why the industry needs to stop picking out curtains when it hasn't built a basement.This week we sit down with Gretchen Gailey: Stab them in the back politics Curtains before basement problem Project Champion playbook | — | ||||||
| 3/19/26 | 15 Years of Cannabis Trading . Why I'll Sell Early (Unless This Happens) ft. Dan McDermitt | Investing in cannabis requires a split personality. Everyone thinks they're early. Dan McDermitt has been trading the sector for 15 years — through the Canadian boom, the Biden promise, and the slow bleed that followed. His take: if you've been through multiple pump-and-dump cycles, you're not early anymore. You're just still here. This is a masterclass in separating trader psychology from fundamental conviction. Dan explains why he keeps a small position just to stay seated, why he already knows he'll sell early on the next catalyst, and why the moment everybody's talking about cannabis on Wall Street Bets is the moment you size up — not before. This week we sit down with Dan McDermitt: The "I'm early" delusion Why traders sell early Catalyst stacking thesis MSOS mechanics breakdown | — | ||||||
| 3/13/26 | Premium vs Scale in Cannabis: Inside Rubicon’s Strategy ft. Margaret Brodie | Most cannabis companies chased scale. Rubicon chased quality. What does it actually take to build a premium cannabis brand? Trust sits behind what “premium” really means, why consumers only give brands one chance, how Rubicon evaluates resource capacity and audits operations, and why Europe could become the next meaningful opportunity for their trusted brands. This week we sit down with Margaret Brodie, CEO of Rubicon Organics: • Why premium cannabis starts with flower• Consumers Trust• Internal Resource Audits | — | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 3/6/26 | Prop 64 Fine Print, Pesticide Drift, The Economics Behind Concentrates ft. Micah Anderson | When California legalized cannabis, did anyone see 70% of the state opting out. Retail access never recovered. The illicit market stayed durable. And taxes kept compounding pressure on operators. Micah Anderson, CEO of LEEF Brands, explains how local bans strengthened the illicit market, why pesticide drift can wipe out millions in product, and why he is rebuilding a recovery and wellness push with NBA player Jimmy Butler. This week we sit down with Micah Anderson: Pesticide drift killing millions Jimmy Butler recovery line Trump’s CBD signal Chapters 00:00 Introduction: California Cannabis Market Challenges 00:31 Prop 64: A Poorly Executed Initiative 01:38 Local Politics and Industry Complexity 02:28 Fixing California Cannabis Policy 03:23 Industry Engagement and Advocacy 04:02 Reevaluating Prop 64 and Market Structure 05:02 Offense vs Defense in Industry Strategy 06:28 Changing Public Perception and Policy Reform 07:36 Industry Regulation and Taxation Issues 08:07 The Role of Advocacy and Industry Voice 09:19 Hindsight and Lessons Learned 10:41 Industry Participation in Policy Making 11:26 CBD and Medical Cannabis Opportunities 12:17 Brand Revival and Market Expansion 13:16 Supply Chain and Cultivation Strategies 14:09 Innovations in Wellness and Recovery Products 15:40 Educational Campaigns and Consumer Awareness 16:39 Research and Clinical Studies in Cannabis 17:08 Regulatory Barriers and Opportunities in Cultivation 18:12 Operational Challenges and Solutions 19:36 Medical Cannabis and Future Legislation 20:29 Supply Chain Management and Quality Control 21:31 Entry of New Participants and Industry Diversification 22:29 Market Expansion and Interstate Commerce 23:24 Pesticide Scrutiny as Industry Moat 24:22 Industry's Role in Consumer Safety and Transparency 25:29 Understanding Pesticide Regulations and Organic Standards 26:55 Supply Chain Variability and Farm Management 28:25 Cost and Efficiency in Cultivation 29:55 Sampling and Testing Challenges 31:33 Expanding Beyond California 33:50 Complexities of Concentrate Production 36:33 Yield Variability and Cultivation Nuances 38:20 Product Development and Customer Collaboration 40:54 Demand Planning and Market Forecasting 42:08 Data-Driven Decision Making in Extraction 44:24 Margins, Product Mix, and Client Relationships 45:47 Market Entry Strategies and Expansion 47:43 Future of Cannabis and International Markets 48:39 Bitcoin and Cannabis: An Evolving Relationship 51:30 Cryptocurrency as a Business Strategy 53:53 Future of Automation and Robotics in Cannabis Production 55:41 Contact and Follow-up Guest links https://www.linkedin.com/in/micah-anderson-leef/ https://leefbrands.com/about/ Resources LEEf Brands Website - https://leefbrands.com UCSD Clinical Study on Sleep and Cannabis - https://ucsd.edu/research/cannabis-sleep-study Elliot Lewis on Pesticide Regulations - https://twitter.com/ElliotLewis California Cannabis Regulations Overview - https://cannabis.ca.gov/regulations/ Bitcoin Official Website - https://bitcoin.org Our Links Bryan Fields on Twitter Kellan Finney on Twitter The Dime on Twitter Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights. At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry. The Dime is a top 5% most shared global podcast The Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished. 🎥 YouTube: The Dime 📸 Instagram: The Dime https://www.newton-insights.com/ | — | ||||||
| 2/27/26 | JB (Cheech & Chong CEO): Building a National Cannabis Brand Through Trial, Error & Partnership | Everyone knows the Cheech & Chong name. Almost no one understands the infrastructure behind it. This isn’t a celebrity brand story. It’s a leverage story inside a fragmented, state-locked cannabis market that could shift overnight. While most operators vertically integrate and hope legislation cooperates, Cheech & Chong are building optionality. Reverse licensing, local partnerships, and asset-light expansion aren’t branding tactics , they’re positioning moves. This week we sit down with Jonathan Black to discuss. How they are using reverse IP licensing MSO vs Big Tobacco Alcohol vs GLP-1 vs Hemp Beverages Chapters 00:00 Introduction and Brand Infrastructure 00:10 JB's Vision for Cheech and Chong 01:07 Market Infiltration and Consumer Experience 02:20 Cheech and Chong's Brand Recognition and Growth 03:06 State-Level Strategies and MSO Dynamics 04:30 Building Ecosystems and Partner Collaboration 05:55 Shelf Space and Local Market Strategies 07:16 Establishing a National Brand in Cannabis 08:34 Trial and Error in Market Entry 09:02 Terpene Profiles and Product Consistency 10:01 Adapting to Different State Systems 11:12 Working with Dispensaries and Partners 12:08 Tools and Technology in Market Monitoring 13:24 Partnering with Celebrities and Influencers 14:23 Advertising Strategies and Consumer Awareness 15:17 Measuring Success and Market Penetration 17:37 Market Footprint and Future Opportunities 18:35 Expanding into New Markets and Countries 20:25 Product Launch Timing and Market Readiness 21:59 Exclusivity and Distribution Agreements 22:40 Managing State-Specific Regulations 23:07 Reverse Licensing Model Explained 24:42 Long-term Industry Outlook and Legislation 27:30 Industry Challenges and Opportunities 29:29 Big Tobacco and MSO Strategies 32:08 Hemp vs Cannabis Market Dynamics 34:14 Legislative Outlook and Industry Legislation 36:29 Cannabis as a Functional Beverage Alternative 38:42 Impact of Legislation on Market Growth 40:29 Celebrity Endorsements and Brand Building 42:31 Future Industry Scenarios and Opportunities 44:56 Getting in Touch and Industry Collaboration Summary In this in-depth interview, industry expert JB discusses the strategic growth of Cheech and Chong's brand in the cannabis and hemp markets, navigating state regulations, and the future of interstate commerce. Gain insights into brand expansion, licensing models, and industry challenges. Guest Links: https://www.linkedin.com/in/jonathan-black-520a7a10/ https://cheechandchong.com/ https://www.forbes.com/sites/willyakowicz/2025/08/24/why-cheech-and-chongs-100-million-cannabis-empire-is-no-joke/ Our Links Bryan Fields on Twitter Kellan Finney on Twitter The Dime on Twitter Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights. At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry. The Dime is a top 5% most shared global podcast The Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished. 🎥 YouTube: The Dime 📸 Instagram: The Dime https://www.newton-insights.com/ | — | ||||||
| 2/19/26 | Cannabis Beverages Are Bringing New Consumers Into Cannabis ft Kristin & Eric Rogers | Beverage may be the most approachable format in cannabis.Familiar ritual. Familiar packaging. Familiar context. Easily Sharable But familiarity creates comparison.Alcohol.That means safety, expectation, and education cannot be left to chance.This week we sit down with Kristin and Eric Rogers of Levia to discuss:• Beverage as a social format• The responsibility of education• Scaling experience across fragmented marketsChapters00:00 Understanding Success in Cannabis Expansion03:08 Brand Consistency Across State Lines05:59 Targeting the Right Consumer Demographics08:55 The Evolution of Cannabis Beverages12:01 Navigating Dosage and Consumer Experience15:02 Quality Control and Supply Chain Management17:50 The Future of Cannabis and Alcohol Beverages21:04 Educating Consumers and Regulators24:07 Navigating Cannabis Regulations in Massachusetts27:24 Understanding Cannabis vs. Alcohol: Safety and Impairment31:10 The Impact of Cannabis on Alcohol Consumption33:43 Educating Consumers: The Importance of Responsible Consumption36:11 Packaging and Communication: Bridging the Knowledge Gap40:04 Challenges in the Cannabis Industry: Patience and PerseveranceSummaryIn this conversation, Bryan Fields and Kristin and Eric Rogers discuss the complexities of the cannabis beverage industry, emphasizing the importance of brand consistency, understanding consumer demographics, and navigating regulatory challenges. They explore the science behind cannabis beverages, the significance of dosage, and the potential future of combining cannabis with alcohol. The discussion also highlights the need for education and awareness among consumers and regulators, as well as the perseverance required to succeed in this evolving industry.Guest Linkshttps://levia.buzz/https://www.linkedin.com/in/eric-rogers12/https://www.linkedin.com/in/kristinhrogers/https://www.linkedin.com/company/leviabrands/Our LinksBryan Fields on TwitterKellan Finney on TwitterThe Dime on TwitterExtraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.The Dime is a top 5% most shared global podcastThe Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished.🎥 YouTube: The Dime📸 Instagram: The Dimehttps://www.newton-insights.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising. | — | ||||||
| 2/13/26 | Hidden Growth Unmasked: Rescheduling, the Farm Bill & What Comes Next ft Trent Woloveck | For the last 18–24 months, reported cannabis growth told an incomplete story. Demand did not plateau.It was fragmented — between hemp channels, illicit markets, and regulated operators. Now, with the Farm Bill loophole closing, Virginia coming online, and rescheduling potentially closer to execution, the numbers begin to look different. And feel different. This week we sit down with Trent Woloveck to discuss: • Why leading with retail first changes everything• The strategic tradeoffs of vertical integration• What true cannabinoid demand actually looks like once distortion fades Chapters 00:00 The Value of Vertical Integration in Cannabis 04:52 Market Dynamics and Capital Allocation 09:34 Virginia's Cannabis Market Evolution 19:04 Impact of Federal Rescheduling on Cannabis 24:38 M&A Challenges in the Cannabis Industry 31:34 Navigating Regulatory Complexities 39:39 The Future of the Cannabis Market 47:27 Looking Ahead: Jushi's Future and Industry Changes Summary In this conversation, Bryan Fields and Trent Woloveck discuss the complexities of the cannabis industry, focusing on vertical integration, market dynamics, and the impact of federal rescheduling. They explore the challenges of capital allocation, the evolution of the Virginia cannabis market, and the difficulties of mergers and acquisitions in a heavily regulated environment. The discussion highlights the importance of understanding market demands and the potential for growth as the industry continues to normalize and expand. Guest Links https://jushico.com https://www.linkedin.com/company/jushi-inc/ https://x.com/two3king Our Links Bryan Fields on Twitter Kellan Finney on Twitter The Dime on Twitter Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights. At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry. The Dime is a top 5% most shared global podcast The Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished. 🎥 YouTube: The Dime 📸 Instagram: The Dime https://www.newton-insights.com/ | — | ||||||
| 2/5/26 | Most Cannabis Marketing Fails Because It Is Asked to Solve the Wrong Problems ft. John Shute | If you doubled your marketing spend tomorrow, would you double your sales? Most cannabis marketing does not fail because teams spend too little. It fails because marketing is asked to create success while known problems remain unfixed. That is why marketing is often the first thing cut when results stall. What has changed is that modern tracking makes attribution clearer and easier than ever. Attribution means understanding which actions actually drive revenue, not just traffic or activity. This week we sit down with John Shute to discuss: • Why marketing gets blamed for upstream failures• How attribution reveals what is actually working• Where most teams are missing Chapters 00:00 Navigating Budget Cuts in Cannabis Marketing 02:59 The Importance of Trackable Marketing Strategies 06:05 Understanding Consumer Behavior and Retention 08:53 Leveraging Data for Brand Growth 11:59 The Role of Email Marketing in Cannabis Brands 15:10 Product Quality and Consumer Safety 18:01 Narrowing Focus for Brand Success 23:26 Smart Growth Strategies in Cannabis Marketing 26:24 The Importance of Data-Driven Decisions 27:21 Closing the Gap: SEO and Market Positioning 30:27 Maximizing Marketing ROI 33:03 Understanding Marketing Attribution 36:14 Navigating Challenges in Client Relationships 39:19 The Complexity of Marketing in Cannabis 45:04 Community Engagement and Social Responsibility Summary In this conversation, John Shute discusses the challenges and strategies of marketing within the cannabis industry, particularly in the context of budget cuts. He emphasizes the importance of trackable marketing efforts, such as email marketing, and the need for brands to focus on consumer retention and data analytics. John also highlights the significance of building a strong brand identity and ensuring product quality and consumer safety. The discussion touches on the evolving landscape of cannabis marketing, the necessity for comprehensive audits, and the value of community engagement initiatives. Guest Links https://x.com/johnshute_ https://www.linkedin.com/in/john-shute-pufcreativ/ https://www.instagram.com/pufcreativ/ https://www.youtube.com/channel/UCY2pdmT1-QHKux8728PRy2A https://www.linkedin.com/company/pufcreativ https://pufcreativ.com/ Our Links Bryan Fields on Twitter Kellan Finney on Twitter The Dime on Twitter Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights. At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry. The Dime is a top 5% most shared global podcast The Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished. 🎥 YouTube: The Dime 📸 Instagram: The Dime https://www.newton-insights.com/ | — | ||||||
| 1/29/26 | How Top Teams Balance Art and Process in Extraction ft. Brian Adams | Exceptional extraction has long been treated as an art.What separates the best teams is not creativity.It is the ability to repeat quality, consistently. And it is not SOP alone. It is judgment applied consistently under real constraints. Constraints that define what is technically possible, operationally realistic, and economically viable. Those constraints tart with understanding your system and tracking the right operational parameters at a level of detail most teams never reach. That depth of understanding is what allows teams to produce a consistent, high-quality end product instead of relying on feel or memory. This week we sit down with Brian Adams to discuss How to balance SOPs with operator flexibility How to think clearly about your extraction system and its limits Whether rolling back adult use in Massachusetts is real or noise Chapters 00:00 The Complexity of Extraction Processes 03:06 Adapting SOPs for Optimal Results 06:04 Understanding Cost Structures in Extraction 09:12 The Importance of Hardware in Product Quality 12:07 Navigating Consumer Expectations and Feedback 15:10 Quality Control and Brand Reputation 18:11 Expanding Product Categories and Maintaining Standards 21:07 Educating Consumers on Concentrate Differences 23:56 The Future of the Cannabis Industry in Massachusetts 30:32 The Current State of Cannabis in Massachusetts 34:27 The Threat of Opposition and Industry Response 39:55 Navigating Negative Perceptions and Future Outlook 41:14 The Importance of Industry Unity and Consumer Education 42:29 Engaging with Consumers and Building a Brand Summary In this conversation, Bryan Fields and Brian Adams delve into the complexities of extraction processes in the cannabis industry, emphasizing the importance of flexibility in Standard Operating Procedures (SOPs) to achieve optimal results. They discuss the significance of understanding cost structures, the role of hardware in product quality, and the challenges of maintaining brand reputation amidst consumer feedback. The conversation also touches on the need for consumer education regarding concentrate differences and the potential future of the cannabis industry in Massachusetts. In this conversation, Brian Adams discusses the current challenges facing the cannabis industry in Massachusetts, particularly in light of recent negative news and opposition movements. He emphasizes the need for industry unity to combat misinformation and protect the rights of consumers. The discussion also touches on the importance of educating consumers about cannabis production and the potential impact of regulatory changes on the industry. Guest Links: https://www.nimbuscannabisco.com/https://www.nimbuscannabisco.com/ Our Links https://www.nimbuscannabisco.com/ https://www.instagram.com/nimbuscc/ https://www.linkedin.com/company/nimbus-cannabis-co/ https://www.linkedin.com/company/hudson-botanical-processing/ https://www.linkedin.com/in/jb-adams/ Bryan Fields on Twitter Kellan Finney on Twitter The Dime on Twitter Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights. At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry. The Dime is a top 5% most shared global podcast The Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished. 🎥 YouTube: The Dime 📸 Instagram: The Dime https://www.newton-insights.com/ | — | ||||||
| 1/22/26 | Robotics vs Automation in Cannabis Manufacturing ft. Nohtal Partansky | Most cannabis automation fails for a simple reason.It optimizes motion instead of understanding. Automation executes. Robotics adapts.That distinction matters in an industry where variability is unavoidable and capital is limited. This episode breaks down why feedback loops matter more than machines, why fully automated facilities are still far off, and how teams should think about constraints before investing. This week, we sit down with Nohtal Partansky to cover: Why automation breaks under variability Automation vs robotics, clearly defined How to avoid expensive missteps Chapters 00:00 Understanding Automation in Cannabis Manufacturing 03:02 The Role of Robotics vs. Automation 05:45 Consultative Approach to Automation 08:54 Challenges in Cultivation Automation 11:59 Designing for Variability in Automation 15:01 Iterative Development and Customer Feedback 18:08 Identifying Design vs. Customer Issues 21:06 Adapting to Environmental Nuances 23:55 Conveying Value in Automation Solutions 27:09 Strategic Approaches to Automation in Supply Chain 30:10 Optimizing Pre-Roll Production Processes 33:44 Understanding Tolerance Levels in Manufacturing 36:39 Intellectual Property in the Cannabis Industry 42:26 Innovations in Cannabis Manufacturing 45:32 Challenges in Automation and Scaling 50:51 Improving Processes and Training in Cannabis Operations Summary In this conversation, Bryan Fields and Nohtal Partansky delve into the intricacies of automation and robotics within the cannabis manufacturing industry. They discuss the differences between fully automated and automated processes, the consultative approach to implementing automation, and the challenges faced in cultivation. The conversation highlights the importance of feedback loops in robotics, the iterative design process, and the need for a deep understanding of customer needs. They also touch on the significance of protecting intellectual property while fostering innovation in a rapidly evolving industry. Guest Links https://www.instagram.com/sortingroboticsinc/ https://www.youtube.com/@sortingrobotics https://www.linkedin.com/company/sortingrobotics/ https://www.sortingrobotics.com/ https://www.linkedin.com/in/nohtal/ Our Links Bryan Fields on Twitter Kellan Finney on Twitter The Dime on Twitter Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights. At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry. The Dime is a top 5% most shared global podcast The Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished. 🎥 YouTube: The Dime 📸 Instagram: The Dime https://www.newton-insights.com/ | — | ||||||
| 1/15/26 | Building Jaunty Into One of New York’s Top Cannabis Brands ft. Nicolas Guarino | Jaunty’s rise to the top of the New York cannabis market was not an overnight success.It was built through discipline in a market uniquely designed New York’s rollout remains unforgiving.One store openings, supply and demand constraints, and continuous price compression forced every decision into the open. This week we sit down with Nicolas Guarino, Co-Founder and CEO of Jaunty, to break down what it actually takes to survive and scale in one of the most interesting cannabis markets in the country. This week we sit down with Nick to discuss: Why consistency becomes the only real moat as prices fall How New York’s rollout punished assumptions and rewarded preparedness Capital discipline, supplier trust, and avoiding overspend death spirals Chapters 00:00 Introduction to Jaunty and Nicolas Guarino 03:06 The Journey into the Cannabis Industry 06:07 Challenges and Lessons Learned in CBD 09:00 Transitioning to Recreational Cannabis 11:54 Building a Brand in a Competitive Market 15:07 Navigating Market Dynamics and Growth Challenges 18:07 The Importance of Support and Resilience 20:49 Understanding Market Economics and Consumer Behavior 23:55 Future Prospects for Cannabis in New York 31:48 The Economics of Cannabis Production 36:29 The Importance of Consistency in Branding 41:11 Navigating Challenges in Cannabis Operations 46:10 Strategic Planning for Future Growth 51:56 Inventory Management and Cost Control 56:02 Preparing for Market Consolidation 58:11 Final Thoughts and Future Directions About: Nicolas Guarino is Co-Founder and CEO of Jaunty. As a GMP-certified 100% New York company working in cannabis extraction since 2017, Jaunty has been producing and distributing the finest solventless hash, live resin, and distillate cannabis products in its mission to close the gap between flower and oil. With state-of-the-art manufacturing facilities in Hoosick Falls, NY, Jaunty is one of New York's leading companies licensed for all adult-use cannabis supply chain activities outside of retail, including cultivation, processing, manufacturing, and distribution. They produce and distribute one of New York’s best-selling cannabis vape brands, available in all of the state’s licensed dispensaries, and their product portfolio also features gummies, concentrates, and disposable vapes. Summary In this episode, Bryan Fields interviews Nicolas Guarino, co-founder and CEO of Jaunty, discussing his journey in the cannabis industry, the challenges faced in the CBD market, and the transition to recreational cannabis. They explore the importance of brand consistency, financial strategies for growth, and the dynamics of the New York cannabis market. Nicholas shares insights on consumer education, market predictions, and the future vision for Jaunty emphasizing the need for adaptability and resilience in a fast-paced industry. Guest Links https://jaunty.com/ https://x.com/getjaunty https://www.linkedin.com/company/get-jaunty https://www.instagram.com/get_jaunty/ https://www.linkedin.com/in/nicolas-guarino-43939b103/ Our Links: Bryan Fields on Twitter Kellan Finney on Twitter The Dime on Twitter Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights. At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry. The Dime is a top 5% most shared global podcast The Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished. 🎥 YouTube: The Dime 📸 Instagram: The Dime https://www.newton-insights.com/ | — | ||||||
| 1/8/26 | How Charlotte’s Web Unlocked Medical CBD ft. Bill Morachnick | Before CBD was discussed by a President in the Oval Office, it was a medical necessity. The Charlotte Figi story is well documented — and powerful.Not because it was emotional, but because it forced a serious medical conversation. Stories like Charlotte’s change how physicians, regulators, and institutions think about where cannabinoid therapy belongs — not as a last resort, but as a legitimate option. Charlotte’s Web was built around that reality. By recognizing that cannabis does have medicinal properties — and that patients should have access to a plant-based option when it can materially improve quality of life — the company focused on trust, standards, and medical credibility first. This week, we sit down with Bill Morachnick to break down: Why CBD earned acceptance through medical trust, not consumer marketing How physician comfort, reimbursement pathways, and standards changed the conversation CBD in the Oval Office — and what that signals for the future of cannabis Chapters 00:00 Introduction to Charlotte's Web and Bill Morachnick 03:00 The Inspiring Story of Charlotte Figi 05:51 The Executive Order and Its Implications 08:59 The Role of Education in CBD Acceptance 12:12 Challenges and Misconceptions in the Cannabis Industry 15:03 The Future of CBD and Medical Recommendations 18:06 The Impact of Federal Reimbursement on CBD 21:08 Defloria and the Future of Cannabis Research 24:01 Navigating Regulatory Changes and Industry Challenges 27:03 The Importance of Quality and Consistency in CBD Products 30:02 The Potential for Pharmaceutical Collaborations 33:04 Looking Ahead: The Future of CBD and Cannabis 36:13 Final Thoughts and Audience Engagement Summary In this episode, Bryan Fields interviews Bill Morachnick, CEO of Charlotte's Web, discussing the company's inspiring origins, the recent executive order regarding CBD, and the future of cannabis as a medicinal product. Bill shares the powerful story of Charlotte Figi, whose life was transformed by CBD, and emphasizes the importance of education in changing perceptions about cannabis. The conversation also touches on the challenges faced by the industry, the potential for pharmaceutical collaborations, and the impact of federal reimbursement on CBD products. Guest Links: https://www.trycharlottesweb.com/ https://www.charlottesweb.com/ https://www.youtube.com/charlotteswebcbd https://www.instagram.com/charlotteswebcbd/ https://www.linkedin.com/in/bill-morachnick-01318a6/ https://www.linkedin.com/company/charlottesweb/ Our Links: Bryan Fields on Twitter Kellan Finney on Twitter The Dime on Twitter Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights. At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry. The Dime is a top 5% most shared global podcast The Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished. 🎥 YouTube: The Dime 📸 Instagram: The Dime https://www.newton-insights.com/ | — | ||||||
| 1/2/26 | The Playbook Behind Consistent Cannabis Products at Scale ft. Ryan Crandall | Everyone wants their product and brand to be known for consistency .Almost no one is willing to do the difficult work that makes consistency possible. This week we sit down with Ryan Crandall, Chief Commercial Officer at MariMed, to break down: Why most cannabis brands fail at scale — and how process control, not an artisanal mindset, determines who lasts How MariMed engineers consistency across states by centralizing inputs & testing aggressively, What it actually takes to make effects-based products consistent and repeatable Chapters 00:00 Introduction to the Cannabis Industry and Edibles 03:05 The Evolution of Edibles: From Early Days to Now 06:01 Ensuring Consistency Across State Lines 09:09 Quality Control and Testing in Edibles 12:01 Consumer Education and Brand Trust 15:13 MariMed Brand Portfolio and Market Strategy 18:06 Role of R&D in Product Development 21:00 Future Trends and Innovations in Edibles 24:03 Building Relationships with Budtenders and Consumers 27:58 Exploring Cannabinoids: THCV and CBG Effects 30:06 Understanding Edible Experiences and Consumer Expectations 32:00 Responsible Product Development in the Cannabis Industry 33:52 Brand Strategy and Market Penetration in New States 35:51 Innovative Products: Vibations and Consumer Convenience 38:04 Navigating the Hemp Market and Brand Expansion 39:52 Consumer Behavior: Beverages vs. Edibles in Cannabis 44:02 The Importance of Team and Company Culture Guest Links: https://www.marimedinc.com/ https://www.linkedin.com/company/marimed-inc/about/ https://www.linkedin.com/in/ryan-crandall-43133b12/ https://x.com/MariMed_Inc Summary In this episode, Bryan Fields interviews Ryan Crandall, Chief Commercial Officer at MariMed, discussing the evolution of the cannabis industry, particularly focusing on edibles. They explore the importance of consistency in product quality across different states, the role of research and development in product innovation, and the significance of branding and consumer trust. Ryan shares insights into MariMeds diverse product portfolio and their approach to quality control and testing procedures. The conversation also touches on the future of hemp and cannabinoids, as well as the beverage market's impact on consumer behavior. Our Links: Bryan Fields on Twitter Kellan Finney on Twitter The Dime on Twitter Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights. At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry. The Dime is a top 5% most shared global podcast The Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished. 🎥 YouTube: The Dime 📸 Instagram: The Dime https://www.newton-insights.com/ | — | ||||||
| 12/19/25 | Schedule III Changes Everything — This Is Just the Beginning | Schedule III isn’t the finish line.It’s the starting gun. The EO said a lot — but most operators aren’t ready for what it actually means. This week we sit down with Zach Edge and Dr. Matthew Moore to break down: Why Schedule III is guidance, not rules — and why the real impact comes during rulemaking What GMP, CFR, and pharmaceutical-grade manufacturing will actually require from operators Which parts of the supply chain face the biggest disruption as cannabis moves forward Chapters 00:00 Historic Changes in Cannabis Scheduling 03:13 The Impact of Hemp in the New Landscape 06:07 Strategic Shifts for Cannabis Operators 08:59 Navigating Regulatory Changes 11:58 The Role of Pharmacies in the New Market 15:04 Global Trade and Competition in Cannabis 17:53 Research Opportunities and Challenges 21:02 Veterans and the Future of CBD 24:02 The Supply Chain Dynamics 26:47 The Future of Hemp and CBD Products 29:56 Final Thoughts on the Cannabis Industry Summary: In this episode, Bryan Fields discusses the recent changes in cannabis scheduling with experts Zach Edge and Matthew Moore. They explore the implications of the new executive order, particularly regarding hemp and its potential impact on the industry. The conversation delves into the strategic shifts that cannabis operators need to consider, the role of compounding pharmacies, and the opportunities for research that arise from the new regulations. They also discuss the challenges in the supply chain and the potential market dynamics as the industry evolves. Guest Links: https://www.linkedin.com/company/the-rho-advisory/ https://www.linkedin.com/in/zach-edge/ https://www.linkedin.com/in/mmoore09/ Our Links: Bryan Fields on Twitter Kellan Finney on Twitter The Dime on Twitter Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights. At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry. The Dime is a top 5% most shared global podcast The Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished. 🎥 YouTube: The Dime 📸 Instagram: The Dime https://www.newton-insights.com/ | — | ||||||
| 12/11/25 | Inside SNDL’s Hidden Scale: Global Reach & Supply Chain Powerhouse ft. Tyler Robson | SNDL is much bigger than most people realize — with global distribution, massive extraction capacity, and a diversified retail and manufacturing engine that touches nearly every part of the cannabis supply chain.This week we sit down with Tyler Robson, President of SNDL, to break down:• How SNDL became a global manufacturing and retail powerhouse• Why extraction and derivatives are their true competitive edge• How they operate across countries with completely different rules and product formatsChapters00:00 Introduction to Sundial and Tyler Robson02:08 The Complexity of Extraction and Manufacturing04:38 Merging Sundial and Valens: Challenges and Strategies06:11 Sundial's Operations and Global Reach07:39 Firefighting and Problem Solving in Leadership09:52 Data-Driven Decision Making12:44 Navigating Different Regulatory Environments13:55 Core Competencies and Operational Efficiencies15:46 Staying Focused in a Distracted Industry16:18 Sundial's Market Position and Brand Partnerships17:10 Strategic Focus on Texas and Florida19:09 Resource Planning and Flexibility20:42 Continuous Improvement in Manufacturing22:34 Synergies Between Liquor and Cannabis24:48 Future of Cannabis and Liquor Co-Mingling26:30 Emerging International Markets28:23 Potential Partnerships and Collaborations30:08 The Size of the Global Cannabis Opportunity31:31 Strategic Partnerships in the US32:03 Conclusion and Key TakeawaysSummaryIn this episode, Tyler Robson, president of Sundial, shares insights into his journey in the cannabis industry, the complexities of extraction and manufacturing, and the challenges of merging companies. He discusses Sundial's global operations, the importance of data-driven decision making, and the need for focus in a distracted industry. Tyler also highlights the potential for growth in emerging markets and the synergies between the cannabis and liquor industries, while emphasizing the significance of strategic partnerships.Guest Links:https://sndl.com/homepage/default.aspxhttps://www.linkedin.com/in/tyler-robson-a77ba4155/https://www.linkedin.com/company/sndlinc/investors@sndl.comOur Links:Bryan Fields on TwitterKellan Finney on TwitterThe Dime on TwitterExtraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.The Dime is a top 5% most shared global podcastThe Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished.🎥 YouTube: The Dime📸 Instagram: The Dimehttps://www.newton-insights.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising. | — | ||||||
| 12/5/25 | You’re Thinking About Debt Wrong: The Secret to Smart Financing ft. Adam Stettner | Most operators think debt is dangerous. But what if the real problem is how we think about it?The opposite is true: when used correctly, debt is the single biggest growth lever in cannabis. Every major industry scales on borrowed capital — cannabis is the only one still trying to do it alone. This week we sit down with Adam Stettner to discuss:• Why debt — used properly — compounds growth• The difference between smart leverage and over-leverage• How operators can fix cash-flow bottlenecks and scale predictably Chapters 00:00 Introduction to Adam Stettner and FundCanna. 03:05 Adam's Journey into the Cannabis Industry 06:12 Understanding Underwriting in Cannabis Financing 09:05 The Importance of Client-Centric Financing 11:56 Navigating Complex Variables in Cannabis Lending 14:57 Building Infrastructure for Cannabis Financing 17:48 Segmenting the Cannabis Industry for Better Insights 20:55 The Unique Challenges of Cannabis Lending 24:12 The Role of Transparency in Client Relationships 28:23 Building Partnerships for Success 29:29 Funding Options for Operational Efficiency 32:29 Understanding Technology and Business Operations 37:54 Navigating Debt and Financial Strategies 42:10 Using Debt to Accelerate Growth 52:46 Exploring Funding Opportunities Summary In this episode, Bryan Fields and Kellen Finney welcome Adam Stettner, CEO of FundCanna, to discuss the complexities of cannabis financing. Adam shares his journey from the apparel industry to cannabis, emphasizing the importance of understanding the unique challenges of underwriting in this space. He highlights the need for a client-centric approach in lending, the significance of transparency, and the innovative strategies FunCounter employs to navigate the cannabis market. Adam also discusses the importance of knowledge sharing and the metrics that indicate success in cannabis financing. In this conversation, Adam Stettner discusses the importance of building partnerships in the cannabis industry, focusing on how funding can enhance operational efficiency and support business growth. He emphasizes the need for flexible financial solutions that allow businesses to thrive without being constrained by debt. Stettner also highlights the significance of understanding technology and its impact on business operations, advocating for a metrics-based approach to financial decisions. The discussion concludes with insights on leveraging debt as a tool for growth and the importance of fostering relationships in the industry. Guest Links: https://fundcanna.com https://fundcanna.com/about/adam-stettner/ https://www.linkedin.com/in/adamstettner https://www.linkedin.com/company/fundcanna/ About Adam Stettner: Adam has 30 years of business, strategy and leadership experience in both Private and Public Companies. In 2021, Adam believed the timing and opportunity was right for him to bring his passion for business, innovative financing and entrepreneurial spirit to the Cannabis sector by creating funding products for all areas of this early stage, growth industry by founding FundCanna. FundCanna provides short term funding to all areas of the sector; cultivators, manufacturers, vendors, suppliers, distributors and retailers. In just its first year, FundCanna has underwritten roughly 3000 files and funded over 500 unique files bringing much needed liquidity and financing solutions to the legal Cannabis industry. Our Links: Bryan Fields on Twitter Kellan Finney on Twitter The Dime on Twitter Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights. At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry. The Dime is a top 5% most shared global podcast The Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished. 🎥 YouTube: The Dime 📸 Instagram: The Dime https://www.newton-insights.com/ | — | ||||||
| 11/20/25 | How LEVEL Delivers Effects-Based Cannabis Tablets ft. Chris Emerson | Everyone in cannabis talks about effects-based products — almost no one can deliver them consistently. Repeatable experiences require precision and formulation discipline that looks a lot more like pharma than cannabis. And here’s why: most operators don’t treat in-house analytics as essential. But that’s the mistake. Process control isn’t optional — it’s the foundation for delivering the same experience every single time. This week we sit down with Chris Emerson, Founder of LEVEL, to break down:• How true effects-based products are actually built• The analytics and standardization required for repeatability• Why most teams can’t achieve consistency — and what it takes to fix it Chapters 00:00 Introduction to Chris Emerson and Level 03:07 The Journey into Cannabis and Product Development 06:02 Challenges in Consistency and Formulation 08:48 Navigating the Market and Consumer Education 12:05 The Role of Cannabinoids and Future Innovations 14:56 Expanding Beyond California: Challenges and Strategies 27:32 The Importance of Consistency in Product Quality 29:51 Navigating the Medical vs Recreational Cannabis Landscape 33:03 Advanced Analytics in Cannabis Production 36:02 Innovations in Product Formulation and Consumer Experience 39:56 Strategic Approaches to Hemp and Cannabinoid Research 45:00 Exploring the Future of Cannabinoids and Consumer Education Summary In this conversation, Chris Emerson, founder of Level, shares his journey from academia to the cannabis industry, discussing the challenges and innovations in product development. He emphasizes the importance of effects-based formulations, consistency in product quality, and the need for consumer education in a rapidly evolving market. The discussion also touches on the future of cannabinoid products and the strategies for expanding into new markets while maintaining quality and consistency. In this conversation, Chris Emerson discusses the complexities of cannabis production, emphasizing the importance of consistency and advanced analytics in ensuring product quality. He explores the challenges faced by the medical cannabis market as it competes with recreational use, and shares insights on the evolving landscape of cannabinoid research, particularly focusing on the Varin class and acidic cannabinoids. The discussion also touches on strategic approaches to hemp and the significance of consumer education in navigating the cannabis industry. Guest Links: https://www.linkedin.com/in/chris-emerson-ph-d-464b245a/ https://www.instagram.com/level.experience https://www.linkedin.com/company/levelexperience/ https://levelexperience.com/ Our Links: Bryan Fields on Twitter Kellan Finney on Twitter The Dime on Twitter Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights. At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry. The Dime is a top 5% most shared global podcast The Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished. 🎥 YouTube: The Dime 📸 Instagram: The Dime https://www.newton-insights.com/ | — | ||||||
| 11/14/25 | What Tobacco and Alcohol Taught Me About Cannabis. ft. Nick Kenny | Tobacco and alcohol are already laying the groundwork for cannabis — building IP, infrastructure, and data. Nick Kenney breaks down what legacy industries already understand — how regulated markets are built, and why readiness always beats speed. This week we sit down with Nick Kenny to discuss:• How tobacco and alcohol are entering cannabis• The playbook for building standardized, scalable systems• Why predictability and timing will define the next wave of winners Chapters 00:00 Introduction to the Cannabis Industry Journey 02:54 The Evolution of Cannabis Perception 06:02 Navigating Regulatory Challenges 08:48 Tobacco and Alcohol Industry Perspectives 11:59 The Role of Research and Development 14:58 Long-Term Strategies vs. Short-Term Survival 18:10 Consumer Behavior and Market Trends 21:03 The Importance of Data in Decision Making 23:58 Collaboration and Networking in the Industry 27:04 Future Outlook and Industry Innovations Summary In this episode, Bryan Fields and Kellan Finney engage with Nick Kenney, a Global Strategic Advisor, to explore the evolving landscape of the cannabis industry. Nick shares his journey from the tobacco sector to cannabis, highlighting the significant shifts in perception and investment within the industry. The conversation delves into the regulatory challenges, the perspectives of tobacco and alcohol companies, and the importance of research and development. They discuss the need for long-term strategies, the impact of consumer behavior, and the critical role of data in decision-making. Nick emphasizes the value of networking and collaboration in the cannabis space, while also providing insights into future innovations and market trends. Guest Links: https://www.kbsstrategicadvisors.com/ https://www.linkedin.com/company/kbsstrategicadvisory/ https://www.linkedin.com/in/nicholasjkenny/ Our Links: Bryan Fields on Twitter Kellan Finney on Twitter The Dime on Twitter Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights. At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry. The Dime is a top 5% most shared global podcast The Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished. 🎥 YouTube: The Dime 📸 Instagram: The Dime https://www.newton-insights.com/ | — | ||||||
Showing 25 of 301
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.